A multiplex PCR method has been developed to classify extended spectrum β-lactamase (ESBL) and plasmidmediated AmpC β-lactamase (PABL). This method consists of the use of two four-multiplex PCRs for the detection of TEM, OXA, SHV, CTX-M, CMY, and DHA type β-lactamases. We have compared findings from the use of conventional detection methods with that of this newly developed typing method. In testing for 73 ESBLproducing and PABL-producing isolates, 100% of the isolates were correctly identified as previously characterized types and, 44 types of β-lactamases were additionally identified from 33 isolates. This assay not only reduces the time for classification but also increases the accuracy for detection.
In this study, we described a multiplex PCR method to classify common ESBLs and PABLs and we evaluat- Seventy-three (3 Enterobacter cloacae, 12 Escherichia coli, 21 Shigella sonnei, and 37 Klebsiella pneumoniae isolates) ESBL-producing and PABL-producing isolates obtained from the Korea Centers for Disease Control and Seoul National University Children's Hospital collection were used in this study (6, 7) . All isolates were previously typed for β-lactamase according to usinge the of a conventional method. lahey.org/studies/webt.asp) ( We optimized the conditions of both multiplex PCR reactions to ensure that each amplicon was of the correct size and that a sufficient quantity of product was generated to permit easy detection after gel electrophoresis ( Fig. 1) . All of the Set I and Set II assays produced single or multiplexed products of the predicted sizes (Fig. 1 ). After optimization, the assay method was tested on the 73 isolates that produced ESBLs, PABLs or both, where the isolates had already been confirmed by the use of conventional methods. Of the previously known ESBLs and PABLs, those produced by each of the 73 tested isolates were successfully identified with the use of the multiplex assays. We identified additional bla genes from 33 isolates (3 E. cloacae, 4 E. coli, 9 S. sonnei, and 17 K.
pneumoniae) that had not been previously identified with the use of conventional methods ( we have developed a fast and accurate assay that will be useful in infectious disease control and prevention.
